JPRN-UMIN000011273已完成未知
Effect of aflibercept in wet age-related macular degenaration (wAMD) with retinal pigment epithelium detachment (PED) - Effect of aflibercept in wAMD with PED
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Drusenoid PED 2) Avascular PED 3) GLD of the total lesion area > 12 4) Presence of RPE tears or macular hole 5) Subretinal hemorrhage, scar or macular fibrosis (>50% lesion area) 5) History of Triamcinolone (< 6 months), dexamethasone (< 30 days), intraocular surgery (< 6 months) 6) Vitrectomy, submacular surgery, etc. 7) Active intraocular inflammation 8) Hypersensitivity or allergy to fluorescein, indocyanine green, etc. 9) Pregnancy, lactating woman
研究者
相似试验
进行中（未招募）
不适用
Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMDWet Age-related Macular DegenerationNCT04932980Berner Augenklinik80
尚未招募
不适用
Fellow Eye Effect with Ranibizumab for Age Related Macular DegeneratioACTRN12607000575437Monash University25
尚未招募
不适用
Clinical study of wet age-related macular degeneration with Traditional Chinese medicine and Western medicineITMCTR2200006375Shanghai Eye Disease Prevention and Treatment Center
已完成
4 期
Effect Aflibercept on Ocular PerfusionAnti Vascular Endothelial Growth FactorMacular DegenerationNCT03804099Augenabteilung Allgemeines Krankenhaus Linz20
进行中（未招募）
1 期
Antibody treatment in retinal vein occulsion and the influence on oxygen and blood supplyretinal vein occlusionEUCTR2016-001660-10-ATniversitätsklinik für Augenheilkunde und Optometrie30